Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24282295.
- Also identified by DOI 10.1073/pnas.1320565110 and PMC identifier 3864278.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The relationship between the cells that initiate cancer and the cancer stem-like cells that propagate tumors has been poorly defined. In a human prostate tissue transformation model, basal cells expressing the oncogenes Myc and myristoylated AKT can initiate heterogeneous tumors. Tumors contain features of acinar-type adenocarcinoma with elevated eIF4E-driven protein translation and squamous cell carcinoma marked by activated beta-catenin. Lentiviral integration site analysis revealed that alternative histological phenotypes can be clonally derived from a common cell of origin. In advanced disease, adenocarcinoma can be propagated by self-renewing tumor cells with an androgen receptor-low immature luminal phenotype in the absence of basal-like cells. These data indicate that advanced prostate adenocarcinoma initiated in basal cells can be maintained by luminal-like tumor-propagating cells. Determining the cells that maintain human prostate adenocarcinoma and the signaling pathways characterizing these tumor-propagating cells is critical for developing effective therapeutic strategies against this population.
Medical subject headings
- Adenocarcinoma
- Cell Transformation, Neoplastic
- Neoplasms, Basal Cell
- Phenotype
- Prostatic Neoplasms
- Signal Transduction